These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 8520094)
1. Therapeutic approaches for AIDS-related toxoplasmosis. Behbahani R; Moshfeghi M; Baxter JD Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094 [TBL] [Abstract][Full Text] [Related]
2. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting. Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350 [TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option? Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303 [TBL] [Abstract][Full Text] [Related]
4. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections. Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329 [TBL] [Abstract][Full Text] [Related]
5. Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017. Belk K; Connolly MP; Schlesinger L; Ben-Harari RR Pathog Glob Health; 2018 Dec; 112(8):428-437. PubMed ID: 30526421 [TBL] [Abstract][Full Text] [Related]
6. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings). Dedicoat M; Livesley N Cochrane Database Syst Rev; 2006 Jul; (3):CD005420. PubMed ID: 16856096 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]. Guelar A; Miró JM; Mallolas J; Zamora L; Cardenal C; Gatell JM; Soriano E Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):137-40. PubMed ID: 8011719 [TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients. Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949 [TBL] [Abstract][Full Text] [Related]
9. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis. Zhang Y; Lin X; Lu F Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469 [TBL] [Abstract][Full Text] [Related]
10. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. Arens J; Barnes K; Crowley N; Maartens G S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578 [TBL] [Abstract][Full Text] [Related]
11. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493 [TBL] [Abstract][Full Text] [Related]
12. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183 [TBL] [Abstract][Full Text] [Related]
13. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Dunay IR; Heimesaat MM; Bushrab FN; Müller RH; Stocker H; Arasteh K; Kurowski M; Fitzner R; Borner K; Liesenfeld O Antimicrob Agents Chemother; 2004 Dec; 48(12):4848-54. PubMed ID: 15561866 [TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866 [TBL] [Abstract][Full Text] [Related]
15. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans. Wei HX; Wei SS; Lindsay DS; Peng HJ PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212 [TBL] [Abstract][Full Text] [Related]
16. Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments. Miyata N; Yoshimura Y; Hikosaka K; Norose K; Tachikawa N J Infect Chemother; 2020 Mar; 26(3):289-293. PubMed ID: 31711832 [TBL] [Abstract][Full Text] [Related]
17. [Recurrence of cerebral toxoplasmosis in 15 AIDS patients]. Walckenaer G; Leport C; Longuet P; Perronne C; Lacassin F; Vildé JL Ann Med Interne (Paris); 1994; 145(3):181-4. PubMed ID: 8092633 [TBL] [Abstract][Full Text] [Related]
18. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice. Araujo FG; Suzuki Y; Remington JS Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398 [TBL] [Abstract][Full Text] [Related]